Clarivate Plc (NYSE: CLVT), a leading global provider of transformative intelligence, announced the launch of Epidemiology Intelligence™. The new sol...
Astellas Pharma and Poseida Therapeutics, Inc. announced that Xyphos Biosciences, Inc., (a wholly owned subsidiary of Astellas, "Xyphos")...
New state-of-the-art research and development (R&D) facility at Ludwigshafen to expand discovery and development of new medicines across core therape...
German Chancellor Olaf Scholz emphasizes significance for Germany as research location at cornerstone laying ceremony Research center to accelerate biop...
Sandoz, a global leader in generic and biosimilar medicines, is pleased to announce the European Commission's (EC) approval of Pyzchiva® (biosimilar us...
The quest for efficiency without compromising safety and compliance is paramount. This was the central theme of the panel discussion titled "Reimag...
Conference Session Recap: Leveraging AI for Fraud Detection in Pharma - Insights from INTERPHEX 2024 Attendees at INTERPHEX 2024 were treated to a t...
Cytiva, a global leader in life sciences solutions, proudly announces its participation at INTERPHEX 2024, where it will unveil its latest advancements in ...
AES Clean Technology, a leading provider of high-performance cleanroom facilities, has launched its CleanLock ModuleTM today. This revolutionary airlock so...
INTERPHEX 2024, held at the prestigious Javits Center in New York City, serves as a premier platform for showcasing advancements in pharmaceutical and...
The event commences at 10:00 am, welcoming attendees from around the globe to immerse themselves in a dynamic atmosphere of discovery and collaboration. Fr...
Fill4Sure™ provides an innovative solution to the critical challenges drug manufacturers experience throughout the fill-finish process, such as high ...
Observation: ACROBiosystems' relentless commitment to innovation and strategic partnerships underscores its pivotal role in advancing organoid research and...
Leveraging dsm-firmenich’s high quality GMP CBD active pharmaceutical ingredient (API) and leading-edge formulation capabilities, chiefly its bioavai...
© 2025 Biopharma Boardroom. All Rights Reserved.
